Medication info

Bovis Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Bukwang Pharmaceutical Co., Ltd.
Appearance
This medication is a round white film-coated tablet.
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201504123 · Approved 2015.06.24

This product's status changed to Expired on 2025.06.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (e.g., gastritis and ulcers) and Zollinger-Ellison syndrome; prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID therapy. NSAID-induced conditions usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime for maintenance therapy. 2) Gastroesophageal reflux disease Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Bukwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., gastritis and ulcers) and Zollinger-Ellison syndrome; prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • postoperative ulcers
View approved original text

This medicine is used for gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, gastroesophageal reflux disease, etc. It is also administered to prevent Mendelson syndrome prior to anesthesia and is effective in the treatment of postoperative ulcers. It is used for the treatment of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It helps improve various gastrointestinal-related problems.

How to take

Adult dose

○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID therapy. NSAID-induced conditions usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime for maintenance therapy. 2) Gastroesophageal reflux disease Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.

Precautions

This drug should not be used in patients with impaired renal function or those on dialysis. Patients who have had an allergic reaction to this drug or its components should also avoid taking it. It is not administered to patients with a history of acute porphyria, as this medication may exacerbate their symptoms. It is also advisable to avoid use in patients who have undergone upper gastrointestinal surgery, pregnant women, women who may become pregnant, and premature or newborn infants. Patients undergoing dietary restrictions on potassium intake should not take this medicine. Caution is advised when using this drug in patients with impaired liver function, previous drug allergies, the elderly, and those with kidney issues. Patients taking NSAIDs together with this medication, especially elderly patients or those with a history of peptic ulcers, require regular medical check-ups. This drug may mask symptoms of stomach cancer, so patients with gastric ulcers or those over middle age who have recently developed or changed dyspeptic symptoms should confirm malignancy before treatment. Patients with gastric and duodenal ulcers infected with Helicobacter pylori should also receive treatments to eliminate the bacteria. Severely ill patients in intensive care units should be monitored for the risk of gastric stones. The aluminum components in this drug can bind to phosphates, hindering phosphate absorption; hence, patients with hypophosphatemia should be cautious. Patients who have difficulty swallowing may experience respiratory complications after taking this medication, so they should exercise caution. There may be rare cases of severe allergic reactions such as anaphylactic shock during the use of this drug; if symptoms occur, discontinue use immediately and consult medical personnel. Hypersensitivity reactions such as skin rash, urticaria, angioedema, fever, and bronchospasm may also occur, and dosing should be stopped if these symptoms develop. Abnormal results may appear in blood tests, so if systemic weakness, bleeding, fever, or similar symptoms occur, immediate testing is warranted. Symptoms of liver dysfunction may also present; if jaundice or hepatitis symptoms appear, discontinue use. Cardiovascular issues such as arrhythmia or vasculitis have been reported rarely. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal distension. Central nervous system symptoms may include dizziness, drowsiness, confusion, convulsions, insomnia, and headache; attention is necessary if unusual symptoms are present. Hormonal-related symptoms such as gynecomastia, excessive milk secretion, erectile dysfunction, and decreased libido have been reported, though causality is unclear. Myalgia, arthralgia, and in severe cases, rhabdomyolysis may occur; if muscle abnormalities are felt, medical advice should be sought promptly. Skin rash or hair loss symptoms have also been reported rarely, so changes in the skin should be monitored closely. It is recommended not to take this drug for long periods, and routine blood tests, including liver and kidney function tests, should be performed regularly during treatment. Elderly patients, those with chronic lung diseases, and diabetics are at an increased risk of pneumonia and should be cautious. If dizziness or drowsiness occurs after taking this medication, driving or operating hazardous machinery should be avoided. This drug may interact with other medications; thus, if the patient is taking anticoagulants or certain antibiotics and anticonvulsants, they should inform their physician or pharmacist. It is safer not to take this drug during pregnancy or while breastfeeding. Safety for pediatric use has not been established; therefore, it is advisable to avoid use in children. In cases of overdose, emergency measures such as vomiting or gastric lavage may be necessary; thus, immediate hospital visitation is required. This drug may reduce gastric acid secretion and promote bacterial overgrowth in the stomach; hence long-term use requires regular medical examinations, including ophthalmologic evaluations.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • agranulocytosis
  • leukopenia
Show 58 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • aplastic anemia
  • pure red cell aplasia
  • hypoplastic anemia
  • myelodysplastic syndrome
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • feeling of illness
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurry vision
  • involuntary movement disorders
  • impaired consciousness
  • muscular cramps
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • reduced libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • glossitis
  • skin itching
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to keep air and moisture out. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

This medication is a round white film-coated tablet.

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.